Growing population in UK surge the demand for food across the nation. Editing plant genomes to feed a growing population is innovative technology in the agriculture industry. The potential of gene editing to address the growing demand for food has contributed to the growth of CRISPR in the agriculture market in UK. New companies are capitalizing on technology to improve crop production and quality. For instance, Tropic Biosciences (based in Norwich, UK) is using gene-editing technology including CRISPR to optimize and improve crop production. The company used gene-editing techniques for developing disease-resistant bananas and decaffeinated coffee.
Recently, in March 2019, the company has launched a breakthrough GEiGS platform to improve crop protection by combining gene editing and RNAi technologies. The research performed in such companies is supported by external funds that allow such new market players to expand their technologies. For instance, Tropic Biosciences has raised $10 million in Series A funding from a global group of Ag and biotech investors. The oversubscribed round was led by agrifood tech venture funds PontifaxAgTech and Five Seasons Ventures. New York-based tech VC Tekfen Ventures, Swiss VC Emerald Technology Ventures, and Chinese agrifood accelerator Bits x Bites also participated in the round among others.
Due to the growing demand for chicken, the farmers in UK are increasing the production every year. With the increasing production, the prevalence of diseases among chickens is also growing in the country. Poultry animals are facing serious infections such as septicemia, gastroenteritis, respiratory diseases, and mycoplasma infections including the highly infectious Mycoplasma Galliseptum (Gs) and other infectious diseases. Gene-editing technology can allow farmers to protect their animals from these diseases. Due to the growing awareness of poultry science among farmers and the active efforts of the government to flourish healthy production of food from poultries, the country is actively engaged in gene editing research for farm animals. For instance, the Roslin Institute at the University of Edinburgh in collaboration with the Institute Strategic Programme (ISP) used CRISPR to produce pigs that are potentially resistant to Porcine Reproductive and Respiratory Syndrome (PRRS).
Research Methodology
The market study of the UK CRISPR in Agriculture market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.
Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.
Secondary Sources Include
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
1. UK CRISPR in Agriculture Market Research and Analysis by End-users
2. UK CRISPR in Agriculture Market Research and Analysis by Target Type
The Report Covers
Recently, in March 2019, the company has launched a breakthrough GEiGS platform to improve crop protection by combining gene editing and RNAi technologies. The research performed in such companies is supported by external funds that allow such new market players to expand their technologies. For instance, Tropic Biosciences has raised $10 million in Series A funding from a global group of Ag and biotech investors. The oversubscribed round was led by agrifood tech venture funds PontifaxAgTech and Five Seasons Ventures. New York-based tech VC Tekfen Ventures, Swiss VC Emerald Technology Ventures, and Chinese agrifood accelerator Bits x Bites also participated in the round among others.
Due to the growing demand for chicken, the farmers in UK are increasing the production every year. With the increasing production, the prevalence of diseases among chickens is also growing in the country. Poultry animals are facing serious infections such as septicemia, gastroenteritis, respiratory diseases, and mycoplasma infections including the highly infectious Mycoplasma Galliseptum (Gs) and other infectious diseases. Gene-editing technology can allow farmers to protect their animals from these diseases. Due to the growing awareness of poultry science among farmers and the active efforts of the government to flourish healthy production of food from poultries, the country is actively engaged in gene editing research for farm animals. For instance, the Roslin Institute at the University of Edinburgh in collaboration with the Institute Strategic Programme (ISP) used CRISPR to produce pigs that are potentially resistant to Porcine Reproductive and Respiratory Syndrome (PRRS).
Research Methodology
The market study of the UK CRISPR in Agriculture market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.
Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.
Secondary Sources Include
- Financial reports of companies involved in the market.
- Whitepapers, research-papers, and news blogs.
- Company websites and their product catalog.
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
1. UK CRISPR in Agriculture Market Research and Analysis by End-users
2. UK CRISPR in Agriculture Market Research and Analysis by Target Type
The Report Covers
- Comprehensive research methodology of the UK CRISPR in Agriculture market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the UK CRISPR in Agriculture market.
- Insights about market determinants which are stimulating the UK CRISPR in Agriculture market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Table of Contents
1. Report Summary
2. Market Overview and Insights
3. Competitive Landscape
4. Market Determinants
5. Market Segmentation
6. Company Profiles
Companies Mentioned
A selection of companies mentioned in this report includes:
- BASF SE
- Bayer AG
- Caribou Bioscience Inc.
- Cibus Ltd.
- CRISPR Therapeutics AG
- DowDupont Inc.
- E. I. du Pont de Nemours and Company
- Pairwise Plants
- Tropic Biosciences UK, LTD.
